Union Bancaire Privee, Ubp Sa Ionis Pharmaceuticals Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $4.81 Billion
- Q4 2024
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 265 shares of IONS stock, worth $8,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265Holding current value
$8,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$492 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$463 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$337 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$285 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$257 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...